Kyung-Mi Lee

Title: Kyung-Mi Lee: Innovator in Cancer Therapy

Introduction

Kyung-Mi Lee is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer therapy through his innovative research and patented inventions. With a total of 7 patents, Lee's work focuses on enhancing the viability and effectiveness of natural killer cells for therapeutic applications.

Latest Patents

One of his latest patents is the "Expansion culture method for human-derived natural killer cells by using HDAC inhibitor." This invention relates to a method that improves the viability and production yield of natural killer cells, which are crucial for cell therapies, particularly in cancer treatment. By treating these cells with an HDAC inhibitor during in vitro expansion culture, Lee's method significantly reduces cell death, allowing for more effective therapeutic applications.

Another notable patent is the "Human anti-ANTXR chimeric antigen receptor and use thereof." This invention involves a chimeric antigen receptor that specifically targets the anthrax toxin receptor. It includes a nucleic acid encoding the receptor, a vector, and a recombinant cell. This innovation provides a pharmaceutical composition for preventing or treating solid cancers, particularly in patients with pancreatic cancer, where traditional drug administration is often ineffective.

Career Highlights

Kyung-Mi Lee has worked with esteemed institutions such as Korea University Research and Business Foundation and Ajou University Industry-Academic Cooperation Foundation. His research has been pivotal in advancing cancer treatment methodologies and enhancing the understanding of natural killer cell applications.

Collaborations

Lee has collaborated with notable colleagues, including Seon Ah Lim and Yong Sung Kim. These partnerships have fostered a collaborative environment that promotes innovative research and development in the field of cancer therapy.

Conclusion

Kyung-Mi Lee's contributions to cancer therapy through his innovative patents and collaborative efforts highlight his role as a leading inventor in the field. His work continues to pave the way for more effective treatments and improved patient outcomes.